CLSI standards and guidelines are developed for use by the global laboratory community. Purchase clinical laboratory standards documents from our shop.
Join CLSI as a member or volunteer and experience how CLSI brings greater accuracy, efficiency, and safety to the laboratories of members around the world.
CLSI's collaborative approach ensures balanced representation from the global laboratory community to yield unbiased consensus standards for global use.
Through our Partnerships program, CLSI provides international outreach services and hands-on support to laboratories in resource-constrained countries, helping them achieve sustainable quality with systems to better diagnose and treat patients with infectious diseases.
CLSI's quarterly Committees Week Meetings bring volunteers together to focus on document development in a consensus-based setting. View upcoming meetings.
The Clinical & Laboratory Standards Institute (CLSI) is a not-for-profit membership organization dedicated to fostering excellence in laboratory medicine.
Point-of-care testing is increasingly being implemented as a faster and more convenient alternative to traditional laboratory testing, particularly in facilities without a lab on the premises. Learn about best practice guidelines for point-of-care testing, how to set up and manage a point-of-care testing program in your facility, and how to reduce testing errors with CLSI’s point-of-care testing standards.
This guideline provides consensus guidelines for health care professionals, in vitro diagnostic and medical device manufacturers, and regulatory agencies regarding the use of continuous glucose monitoring (CGM) systems and data obtained from CGM systems. This guideline covers how CGM data should be assessed for accuracy, how CGM systems should be assessed for factors that can decrease accuracy, and how CGMs should be operated for optimal performance.
This guideline provides recommendations to users and manufacturers of point-of-care coagulation testing devices for monitoring heparin and vitamin K antagonist therapy and for the evaluation of hemostasis, as well as to ensure reliable results comparable with those obtained by routine medical laboratory testing.
CLSI uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our privacy policy.
